SNCA and Parkinson disease: To illustrate, the brain extracts of MSA patients, not PD patients, showed increased neural atrophy and functional loss once injected into the transgenic mice, implying that the α-synuclein strains obtained from MSA patients may exhibit a higher toxicity [17].